Status:
COMPLETED
Long Term Follow-up Study of Safety and Efficacy of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence
Lead Sponsor:
Allergan
Conditions:
Overactive Bladder
Urinary Incontinence
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to assess the long term safety and effectiveness of botulinum toxin type A in treating patients with idiopathic overactive bladder with urinary incontinence.
Eligibility Criteria
Inclusion
- Participation in preceding study 191622-095 (NCT00910845) or 191622-520 (NCT00910520)
Exclusion
- Females who are pregnant, nursing or planning a pregnancy
- Patient has any condition or situation which, in the Investigators opinion, would put the patient at risk from continuing treatment with botulinum toxin Type A
Key Trial Info
Start Date :
February 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 5 2014
Estimated Enrollment :
829 Patients enrolled
Trial Details
Trial ID
NCT00915525
Start Date
February 1 2010
End Date
August 5 2014
Last Update
April 30 2019
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Newport Beach, California, United States
2
Ghent, Belgium
3
Victoria, British Columbia, Canada
4
Prague, Czechia